398 related articles for article (PubMed ID: 32085881)
1. Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease.
Sukocheva OA; Lukina E; McGowan E; Bishayee A
Adv Protein Chem Struct Biol; 2020; 120():123-158. PubMed ID: 32085881
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.
Sukocheva OA; Furuya H; Ng ML; Friedemann M; Menschikowski M; Tarasov VV; Chubarev VN; Klochkov SG; Neganova ME; Mangoni AA; Aliev G; Bishayee A
Pharmacol Ther; 2020 Mar; 207():107464. PubMed ID: 31863815
[TBL] [Abstract][Full Text] [Related]
3. Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.
Sukocheva OA; Neganova ME; Aleksandrova Y; Burcher JT; Chugunova E; Fan R; Tse E; Sethi G; Bishayee A; Liu J
Cell Commun Signal; 2024 May; 22(1):251. PubMed ID: 38698424
[TBL] [Abstract][Full Text] [Related]
4. Novel therapeutic targets for inflammatory bowel disease.
Argollo M; Fiorino G; Hindryckx P; Peyrin-Biroulet L; Danese S
J Autoimmun; 2017 Dec; 85():103-116. PubMed ID: 28711286
[TBL] [Abstract][Full Text] [Related]
5. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
[No Abstract] [Full Text] [Related]
6. Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study.
Suh JH; Degagné É; Gleghorn EE; Setty M; Rodriguez A; Park KT; Verstraete SG; Heyman MB; Patel AS; Irek M; Gildengorin GL; Hubbard NE; Borowsky AD; Saba JD
Inflamm Bowel Dis; 2018 May; 24(6):1321-1334. PubMed ID: 29788359
[TBL] [Abstract][Full Text] [Related]
7. The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases.
Zou F; Wang S; Xu M; Wu Z; Deng F
Front Physiol; 2023; 14():1235656. PubMed ID: 37560160
[TBL] [Abstract][Full Text] [Related]
8. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
9. [The place of sphingosine-1-phosphate modulators in the therapy of inflammatory bowel diseases].
Szymaszkiewicz K; Szymaszkiewicz A; Fichna J
Postepy Biochem; 2020 Mar; 66(1):42-48. PubMed ID: 33320478
[TBL] [Abstract][Full Text] [Related]
10. Modulation of sphingosine-1-phosphate in inflammatory bowel disease.
Peyrin-Biroulet L; Christopher R; Behan D; Lassen C
Autoimmun Rev; 2017 May; 16(5):495-503. PubMed ID: 28279838
[TBL] [Abstract][Full Text] [Related]
11. Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Jan; 56(1):174-185. PubMed ID: 29687345
[TBL] [Abstract][Full Text] [Related]
12. Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration.
Danese S; Furfaro F; Vetrano S
J Crohns Colitis; 2018 Aug; 12(suppl_2):S678-S686. PubMed ID: 28961752
[TBL] [Abstract][Full Text] [Related]
13. Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis - a unique therapeutic target in inflammatory bowel disease.
Wang J; Goren I; Yang B; Lin S; Li J; Elias M; Fiocchi C; Rieder F
Aliment Pharmacol Ther; 2022 Feb; 55(3):277-291. PubMed ID: 34932238
[TBL] [Abstract][Full Text] [Related]
14. Unravelling the interplay of sphingolipids and TGF-β signaling in the human corneal stroma.
Nicholas SE; Rowsey TG; Priyadarsini S; Mandal NA; Karamichos D
PLoS One; 2017; 12(8):e0182390. PubMed ID: 28806736
[TBL] [Abstract][Full Text] [Related]
15. S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancer.
Degagné E; Saba JD
Clin Exp Gastroenterol; 2014; 7():205-14. PubMed ID: 25061328
[TBL] [Abstract][Full Text] [Related]
16. Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming.
Sukocheva OA
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385066
[TBL] [Abstract][Full Text] [Related]
17. The Crosstalk between FcεRI and Sphingosine Signaling in Allergic Inflammation.
Jo H; Shim K; Jeoung D
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430378
[TBL] [Abstract][Full Text] [Related]
18. Unveiling the biological role of sphingosine-1-phosphate receptor modulators in inflammatory bowel diseases.
Tourkochristou E; Mouzaki A; Triantos C
World J Gastroenterol; 2023 Jan; 29(1):110-125. PubMed ID: 36683721
[TBL] [Abstract][Full Text] [Related]
19. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
[TBL] [Abstract][Full Text] [Related]
20. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.
Nagahashi M; Yamada A; Katsuta E; Aoyagi T; Huang WC; Terracina KP; Hait NC; Allegood JC; Tsuchida J; Yuza K; Nakajima M; Abe M; Sakimura K; Milstien S; Wakai T; Spiegel S; Takabe K
Cancer Res; 2018 Apr; 78(7):1713-1725. PubMed ID: 29351902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
